Skip to content

Construction and application of a comprehensive nursing management system for nasal endoscopic surgery based on real-world big data analysis

Construction and application of a comprehensive nursing management system for nasal endoscopic surgery based on real-world big data analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100919
Enrollment
Unknown
Registered
2025-04-17
Start date
2021-03-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasosinusitis

Interventions

Observation group:None

Sponsors

The Third Military Medical University of the Chinese People's Liberation Army (Army Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years.with chronic sinusitis who have undergone endoscopic surgery. Voluntarily enrolled in this study, signed an informed consent form, had good compliance and were willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1) Participants who have received radiotherapy, chemotherapy, surgery (excluding local biopsy) or molecular targeted therapy within 4 weeks prior to enrollment; or who have received anti-tumor endocrine therapy after screening period. 2) Participants with a history of other malignant tumors. 3) Participants with a history of immune deficiency, including positive HIV test, or other acquired or congenital immune deficiency diseases, or a history of organ transplantation. 4) Participants with any history of cardiovascular disease, including: 1) cardiac arrhythmia requiring medication or of clinical significance; 2) myocardial infarction; 3) heart failure; 4) any other cardiovascular disease deemed by the investigator to be unsuitable for participation in this trial, etc. 5) Participants with a history of a definitive neurological or psychiatric disorder, including epilepsy or dementia. 6) Female patients who are pregnant or breastfeeding, have reproductive potential and have a positive baseline pregnancy test, or are unwilling to take effective contraceptive measures during the trial period. 7) Participants with severe co-existing diseases. 8) Any other situation where the investigator deems the participant unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Nasal conditions;Sinus conditions;Olfactory function score;Surgical related complications;

Secondary

MeasureTime frame
Safety indicators;

Countries

China

Contacts

Public ContactZhang Yan

Second Affiliated Hospital of Army Medical University

327718986@qq.com+86 132 1233 0209

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026